Evidence map›Paper›PMID 25652897›Full record

ArticleNanomedicine : nanotechnology, biology, and medicine2015

Atherosclerotic neovasculature MR imaging with mixed manganese-gadolinium nanocolloids in hyperlipidemic rabbits.

Kezheng Wang, Dipanjan Pan, Anne H Schmieder, Angana Senpan, Shelton D Caruthers, Grace Cui, John S Allen, Huiying Zhang, Baozhong Shen, Gregory M Lanza

Open access · greenAbstract read
In one paragraph

Article in Nanomedicine : nanotechnology, biology, and medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Kezheng WangDepartment of Radiology, the Fourth Hospital of Harbin Medical University and Molecular Imaging Center of Harbin Medical University, Harbin, China; Division of Cardiology, Washington University School of Medicine, St. Louis, MO, USA.
Dipanjan PanDivision of Cardiology, Washington University School of Medicine, St. Louis, MO, USA.
Anne H SchmiederDivision of Cardiology, Washington University School of Medicine, St. Louis, MO, USA.
Angana SenpanDivision of Cardiology, Washington University School of Medicine, St. Louis, MO, USA.
Shelton D CaruthersDivision of Cardiology, Washington University School of Medicine, St. Louis, MO, USA.
Grace CuiDivision of Cardiology, Washington University School of Medicine, St. Louis, MO, USA.
John S AllenDivision of Cardiology, Washington University School of Medicine, St. Louis, MO, USA.
Huiying ZhangDivision of Cardiology, Washington University School of Medicine, St. Louis, MO, USA.
Baozhong ShenDepartment of Radiology, the Fourth Hospital of Harbin Medical University and Molecular Imaging Center of Harbin Medical University, Harbin, China. Electronic address: shenbzh@vip.sina.com.
Gregory M LanzaDivision of Cardiology, Washington University School of Medicine, St. Louis, MO, USA. Electronic address: greg.lanza@me.com.
Washington University in St. Louis · USFourth Affiliated Hospital of Harbin Medical University · CN

Funding

Theranostic Approach to Asthma Using Anti-Angiogenic NanomedicineR01HL113392 · NHLBI · WASHINGTON UNIVERSITY · PI LANZA, GREGORY M, WAGNER, ELIZABETH · 2012 to 2016
$3.3M
NEXT GENERATION APPROACHES TO BREAST CANCER USING IMAGE GUIDED DRUG DELIVERYR01CA154737 · NCI · WASHINGTON UNIVERSITY · PI LANZA, GREGORY M, PAN, DIPANJAN · 2011 to 2015
$2.4M
Combined Therapeutic-Imaging Agent for AtherosclerosisR01HL078631 · NHLBI · WASHINGTON UNIVERSITY · PI LANZA, GREGORY M · 2004 to 2007
$1.5M
COLLOIDAL IRON-OXIDE NANOBEACONS FOR THERANOSTIC USE IN ATHEROSCLEROSISR01HL094470 · NHLBI · WASHINGTON UNIVERSITY · PI LANZA, GREGORY M · 2009 to 2010
$1.4M
Targeted Nanoparticles of Bismuth Organo Complexes for Spectral CT Imaging of CorR42HL112518 · NHLBI · OCEAN NANOTECH, LLC · PI LANZA, GREGORY M, WANG, YONGQIANG ANDREW · 2012 to 2015
$1.4M
Molecular Imaging of Angiogenesis by MRIR01EB001704 · NIBIB · WASHINGTON UNIVERSITY · PI LANZA, GREGORY M · 2004 to 2007
$946k
Prevention of Bladder Cancer with Broccoli SproutsR21CA100623 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI ZHANG, YUESHENG · 2004 to 2005
$466k
NCI NIH HHS CA100623NCI NIH HHS CA154737NCI NIH HHS HHSN268201400042CAWNCI NIH HHS R01 CA154737NCI NIH HHS R21 CA100623NHLBI NIH HHS HL112518NHLBI NIH HHS HL113392NHLBI NIH HHS R01 HL078631NHLBI NIH HHS R01 HL094470NHLBI NIH HHS R01 HL113392NHLBI NIH HHS R42 HL112518NIBIB NIH HHS R01 EB001704
6 · The paper itself

Abstract

A high r1 relaxivity manganese-gadolinium nanocolloid (αvβ3-MnOL-Gd NC) was developed and effectively detected atherosclerotic angiogenesis in rabbits fed cholesterol-rich diets for 12 months using a clinical MRI scanner (3T). 3D mapping of neovasculature signal intensity revealed the spatial coherence and intensity of plaque angiogenic expansion, which may, with other high risk MR bioindicators, help identify high-risk patients with moderate (40% to 60%) vascular stenosis. Microscopy confirmed the predominant media and plaque distribution of fluorescent αvβ3-MnOL-Gd NC, mirroring the MR data. An expected close spatial association of αvβ3-integrin neovasculature and macrophages was noted, particularly within plaque shoulder regions. Manganese oleate bioelimination occurred via the biliary system into feces. Gd-DOTA was eliminated through the bile-fecal and renal excretion routes. αvβ3-MnOL-Gd NC offers an effective vehicle for T1w neovascular imaging in atherosclerosis. From the clinical editor: Cerebrovascular accidents are a leading cause of mortality and morbidity worldwide. The acute formation of thrombus following atherosclerotic plaque rupture has been well recognized as the etiology of stroke. The authors studied microanatomical features of vulnerable atherosclerotic plaque in this article, in an attempt to identify those with high risk of rupture. Gadolinium-manganese hybrid nanocolloid (MnOL-Gd NC) was developed as a novel contrast agent for MRI. They show that this agent is effective in providing neovascular imaging.

Indexed as

AnimalsAtherosclerosisColloidsContrast MediaGadoliniumHyperlipidemiasManganeseNeovascularization, PathologicPlaque, AtheroscleroticRabbitsRadiographyColloidsContrast MediaGadoliniumManganeseAngiogenesisAtherosclerosisContrast mediaMolecular imagingMRINanotechnology

Identifiers

PMID25652897
PMCPMC4720435
OpenAlexW2133206873

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.